Lenalidomide in the context of complex karyotype or interrupted treatment: case reviews of del(5q)MDS patients with unexpected responses.
about
The role of lenalidomide in the management of myelodysplasia with del 5q.Lenalidomide: a brief review of its therapeutic potential in myelodysplastic syndromes.Combination of azacitidine and lenalidomide in myelodysplastic syndromes or acute myeloid leukemia-a wise liaison?Long-term hematological response in a patient with 5q- syndrome after suspension of lenalidomide therapy and further improvement with deferasirox therapy.Erythroid but not cytogenetic response in a case with 5q- syndrome: a delayed effect of lenalidomide or a consequence of deferasirox treatment?Long-Term Maintenance of Hematological and Cytogenetic Remission in 5q- Syndrome After Short-Term Administration of Lenalidomide.Lenalidomide for myelodysplastic syndromes with del(5q): how long should it last?Isolated del(5q) in myeloid malignancies: clinicopathologic and molecular features in 143 consecutive patients.
P2860
Q33378398-678B782E-6496-4635-AE4F-24582BD099E0Q33379562-18E08AC9-5674-47CA-91B2-9613929F380AQ34342944-33C2B250-3EFD-41E5-BA19-E7A1C915FD9EQ41964641-6A213D6B-C171-4B17-B9DD-479A289426ECQ45971495-B0FCA427-5BE4-485D-9195-11C0495D4E12Q48212594-6F19EBED-19AE-4CE3-99A5-D1D850CD55C5Q50556796-D41B1833-22DD-4CC1-BDBC-AF03A014E138Q54594035-1E9F7F80-9C6B-4E8E-9278-64802CD58620
P2860
Lenalidomide in the context of complex karyotype or interrupted treatment: case reviews of del(5q)MDS patients with unexpected responses.
description
2006 nî lūn-bûn
@nan
2006 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Lenalidomide in the context of ...... nts with unexpected responses.
@ast
Lenalidomide in the context of ...... nts with unexpected responses.
@en
type
label
Lenalidomide in the context of ...... nts with unexpected responses.
@ast
Lenalidomide in the context of ...... nts with unexpected responses.
@en
prefLabel
Lenalidomide in the context of ...... nts with unexpected responses.
@ast
Lenalidomide in the context of ...... nts with unexpected responses.
@en
P2093
P2860
P50
P1433
P1476
Lenalidomide in the context of ...... nts with unexpected responses.
@en
P2093
Gudrun Göhring
Michael Heinsch
Sabine Haase
P2860
P304
P356
10.1007/S00277-006-0217-Y
P577
2006-11-17T00:00:00Z